"Fortis Memorial Research Institute is a multi-super-speciality, quaternary care hospital with an enviable international faculty, reputed clinicians, including super-sub-specialists and speciality nurses, supported by cutting–edge technology. A premium referral hospital, it endeavours to be the 'Mecca of Healthcare' for Asia Pacific and beyond. Set on a spacious 11-acre campus , this 'Next Generation Hospital' is built on the foundation of 'Trust' and rests on four strong pillars: Talent, Technology, Service and Infrastructure"

During the past decade, Fortis Memorial Research Institute conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fortis Memorial Research Institute" #1 sponsor was "Pfizer" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Fresenius Kabi" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fortis Memorial Research Institute" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Fortis Memorial Research Institute" are "Ulcerative Colitis" (3 trials), "Crohn's Disease" (2 trials), "Multiple Myeloma" (2 trials), "Bradycardia" (1 trials) and "Caloric Deficit" (1 trials). Many other conditions were trialed in "Fortis Memorial Research Institute" in a lesser frequency.

Most popular intervention types in "Fortis Memorial Research Institute" are "Drug" (12 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Etrasimod" (4 trials), "Dexamethasone" (2 trials), "Lenalidomide" (2 trials) and "Teclistamab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fortis Memorial Research Institute" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Fortis Memorial Research Institute". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Fortis Memorial Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fortis Memorial Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".